Stem cell research

Stem cell research

Stem cell research plays a central role in longevity research, as stem cells have the ability to differentiate into different cell types and repair damaged tissue. This regenerative ability is of crucial importance when it comes to combating age-related diseases and preserving the function of organs and tissues.

Stem cells can be broadly divided into two main types: embryonic stem cells and adult stem cells. Embryonic stem cells have the potential to transform into any cell type in the body, while adult stem cells, which are found in various tissues, are more specialized but still have the potential to replace damaged cells. This regenerative capacity is being used in research to treat degenerative diseases such as heart disease, diabetes, osteoporosis and neurodegenerative diseases such as Alzheimer's.

Another exciting area is the development of induced pluripotent stem cells (iPSCs), in which normal somatic cells are reprogrammed to a pluripotent state by reprogramming their genes so that they can differentiate into different cell types like embryonic stem cells. This technology has the potential to enable personalized therapies in which a patient's cells are used to generate new tissues that are not rejected by the immune system.

Applications of stem cell research in longevity research:

  1. Tissue regeneration: Stem cells can be used to repair damaged tissue, such as heart tissue after a heart attack or neuronal cells in neurodegenerative diseases.
  2. Organs in the laboratory: Using 3D bioprinting and stem cell technology, work is underway to grow entire organs in the laboratory that can be transplanted to replace damaged organs.
  3. Anti-ageing therapies: Stem cell-based therapies to rejuvenate skin and other tissues could slow down age-related degeneration and improve appearance.


Stem cell therapies offer enormous potential for longevity research as they directly target the causes of ageing and tissue ageing. By restoring the function of tissues and organs, stem cell research could play a key role in extending lifespan in the future.

Swiss radio and television

Schweizer Radio und Fernsehen (SRF) serves the public with a wide range of high-quality programs. The company promotes the free formation of opinion through comprehensive and factual information, conveys cultural values and provides education and entertainment for the public. With its main studios in Zurich, Basel and Berne and regional studios in Aarau, Chur, Lucerne and St. Gallen, SRF strengthens its roots in the broadcasting region. SRF also has a global network of 60 correspondents who gather information on the ground and provide first-hand background information and assessments. SRF is SRG's largest business unit, comprising a total of 17 radio and 7 television channels as well as supplementary websites and teletext services for four language regions. As a non-profit organization, SRG is financed around 75 percent by licence fees and around 25 percent by commercial revenues. It is politically and economically independent.

To the website